AARON PETERSON: Open Payments
NPI 1861040230 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 69 payments from 14 companies in 2025. Trend: 2023 $826 · 2024 $1,712 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $325 |
| PFIZER INC. | 16 | $281 |
| Merck Sharp & Dohme LLC | 12 | $199 |
| Alnylam Pharmaceuticals Inc. | 5 | $134 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Novo Nordisk Inc | 3 | $95 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| United Therapeutics Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
Products named: REPATHA, VYNDAQEL, AMVUTTRA, VERQUVO, LEQVIO, Wegovy, ELIQUIS, WINREVAIR.
Industry payments across UT — which companies pay providers there.
